EU/3/11/898

About

On 30 August 2011, orphan designation (EU/3/11/898) was granted by the European Commission to Santen Oy, Finland, for sirolimus for the treatment of chronic non-infectious uveitis.

Key facts

Active substance
Sirolimus
Disease / condition
Treatment of chronic non-infectious uveitis
Date of first decision
30/08/2011
Outcome
Positive
EU designation number
EU/3/11/898

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Santen Oy
Niittyhaankatu 20
FI-33720 Tampere
Finland
Telephone: + 358 3 284 8111
Telefax: + 358 3 318 19 00
E-mail: mail@santen.de

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating